LLY
Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 332.31$. Average daily volumn in 3 months 3.19M. Market cap 327.06B
Stock symbol : LLY. Exchange : NYSE. Currency : USD Lastest price : 343.42$. Total volume : 2.87M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Eli Lilly and Company (LLY)
Last Price
343.42$Change
2.73Volume
2.87M
| Previous Close | 340.69 |
| Open | 342.00 |
| Day Range | 340.69-343.65 |
| Bid | 344.00 x 1k |
| Ask | 344.50 x 800 |
| Volume | 2.87M |
| Average Volume | 3.19M |
| Market Cap | 327.06B |
| Beta | 0.35 |
| 52 Week Range | 276.83-375.25 |
| Trailing P/E | 49.63 |
| Foward P/E | 29.33 |
| Dividend (Yield %) | 1.33% |
| Ex-Dividend Date | 2023-02-14 |
Financial Details
Organization
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Market Cap:
327.06BRevenue:
28.54BTotal Assets:
49.49BTotal Cash:
2.07B
News about "Eli Lilly and Company"
Eli Lilly & Co. stock rises Tuesday, outperforms market
Source from : MarketWatch - 3 days ago
Eli Lilly & Co. closed $46.79 short of its 52-week high ($384.44), which the company achieved on January 24th. The stock outperformed some of its competitors Tuesday, as Johnson & Johnson JNJ fell ...See details»
Eli Lilly and Company (NYSE:LLY) is a favorite amongst institutional investors who own 88%
Source from : YAHOO!Finance - 18 days ago
Key Insights Institutions' substantial holdings in Eli Lilly implies that they have significant influence over ...See details»
A Eli Lilly and Company (NYSE:LLY) insider increased their holdings by 1.4% last year
Source from : YAHOO!Finance - 3 days ago
From what we can see, insiders were net buyers in Eli Lilly and Company's ( NYSE:LLY ) during the past 12 months.See details»
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Source from : Nasdaq - 1 month ago
Eli Lilly (LLY) has recently been on ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate ...See details»
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
Source from : Nasdaq - 11 days ago
Eli Lilly (LLY) has recently been on ... Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate ...See details»
Eli Lilly and Company
Source from : Fortune - 9 days ago
© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»
In ninth try, Eli Lilly asks shareholders to end staggered terms for board members
Source from : Ibj.com - 26 days ago
But Eli Lilly and Co. is apparently taking that to the next level—trying for the ninth time since 2010 to overhaul the company’s board structure to force all directors to stand for election ...See details»
Eli Lilly and Company (LLY) Presents at Cowen's 43rd Annual Health Care Conference (Transcript)
Source from : Seeking Alpha - 25 days ago
[Call Starts Abruptly] at the Cowen Conference again this year. Representing the company is Mike Mason, who is President of Lilly Diabetes. So Mike, thank you for making the journey. Lots to cover ...See details»
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression
Source from : CNBC - 23 days ago
Eli Lilly on Wednesday said it will halt development ... trial data on donanemab in the second quarter of this year. The company plans to ask the Food and Drug Administration to approve the ...See details»
Eli Lilly to cut insulin prices, as low as $25 a vial for most common drug
Source from : PBS - 1 month ago
Aside from Eli Lilly and the French drugmaker Sanofi, other insulin makers include the Danish pharmaceutical company Novo Nordisk. Neither company immediately responded to a request for comment ...See details»
Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35
Source from : CBS News - 1 month ago
"Today is really about lowering the cost of older insulins, that's what people expect from our industry," Eli Lilly CEO David Ricks said on a conference call to discuss the company's new pricing ...See details»
‘Hero’ journalist congratulated after Eli Lilly lowers price of insulin after his spoof tweet raised awareness
Source from : Yahoo - 1 month ago
He created an account with the handle @EliLillyAndCo — the company's real handle is @LillyPad — and issued a tweet saying the company planned to make insulin free. The fake tweet was so convincing ...See details»
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
Source from : Benzinga.com - 1 month ago
INDIANAPOLIS, March 1, 2023 /PRNewswire/ -- Eli Lilly and Company LLY today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value ...See details»
Eli Lilly's Insulin Price Cut Not Likely to Extricate It From Legal Morass
Source from : Law - 1 month ago
"If a company has acquired or maintained monopoly power through anticompetitive means, they're liable under the antitrust laws whether or not they're exploiting their monopoly power by charging ...See details»